BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21909806)

  • 1. Aspirin, clopidogrel, and warfarin use and outcomes in a cohort of 580 patients discharged after hospitalization for decompensated heart failure.
    Kozdağ G; Yaymacı M; Ertaş G; Celikyurt U; Sahin T; Kılıç T; Ural D
    Heart Vessels; 2012 Nov; 27(6):568-75. PubMed ID: 21909806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.
    Massie BM; Krol WF; Ammon SE; Armstrong PW; Cleland JG; Collins JF; Ezekowitz M; Jafri SM; O'Connor CM; Packer M; Schulman KA; Teo K; Warren S
    J Card Fail; 2004 Apr; 10(2):101-12. PubMed ID: 15101020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
    Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
    Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review.
    Horning KK; Hoehns JD; Doucette WR
    J Manag Care Pharm; 2007; 13(1):28-36. PubMed ID: 17269834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
    McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
    Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preventing cerebrovascular accidents during atrial fibrillation].
    Ederhy S; Meuleman C; Hammoudi N; Janower S; Boccara F; Cohen A
    Presse Med; 2005 Oct; 34(18):1315-24. PubMed ID: 16269996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.
    Massie BM; Collins JF; Ammon SE; Armstrong PW; Cleland JG; Ezekowitz M; Jafri SM; Krol WF; O'Connor CM; Schulman KA; Teo K; Warren SR;
    Circulation; 2009 Mar; 119(12):1616-24. PubMed ID: 19289640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy in heart failure.
    Verheugt FW
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):277-8. PubMed ID: 16716103
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.
    Di Tullio MR; Qian M; Thompson JL; Labovitz AJ; Mann DL; Sacco RL; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Lip GY; Levin B; Mohr JP; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Homma S;
    Stroke; 2016 Aug; 47(8):2031-7. PubMed ID: 27354224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure.
    Chun S; Tu JV; Wijeysundera HC; Austin PC; Wang X; Levy D; Lee DS
    Circ Heart Fail; 2012 Jul; 5(4):414-21. PubMed ID: 22556322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
    Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of the cardiac triple therapy: the experience of the Quebec Heart Institute.
    Brulotte S; Sénéchal M; Poirier P; Nguyen CM; Lemieux A; Magne J; Bergeron S
    Can J Cardiol; 2007 Oct; 23 Suppl B(Suppl B):80B-83B. PubMed ID: 17932593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Watching the WATCH trial: the role of sponsors and data monitoring committees.
    Califf RM
    J Card Fail; 2004 Apr; 10(2):113-4. PubMed ID: 15101021
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
    Kamath S; Blann AD; Chin BS; Lip GY
    J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapies in patients with heart failure: hypothesis formulation from a research database.
    Yuan Z; Weinstein R; Zhang J; Cheng M; Griffin G; Zolynas R; Plotnikov AN; Lee MS; Oppenheimer L; Burton P
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):911-20. PubMed ID: 20602345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for the secondary prevention of stroke in older patients: the influence of dementia status.
    Moroney JT; Tseng CL; Paik MC; Mohr JP; Desmond DW
    J Am Geriatr Soc; 1999 Jul; 47(7):824-9. PubMed ID: 10404926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.